| CGON Market Cap History Table | ||||||||||||||||||||
Below is a table of the CGON market cap history going back to 5/9/2024:
Also see: CGON Shares Outstanding History and CGON YTD Return |
CGON Market Cap History — CG Oncology Capitalization Over Time
As of 8/5/2026 CG Oncology has a market cap of 6.42 billion. Investors often follow the CGON market cap history to compare the size of the company over time.
This page shows CGON market capitalization trends over time, with 9 market cap datapoints presented, dating back to 5/9/2024.
| CGON Market Cap History Chart | |||||||||||||||||||||||||||
CGON Historical Market Cap: +68.24% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||
| CGON Stock Price Chart |
| About CG Oncology Inc |
| CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene, for patients with bladder cancer. Co. is at a clinical stage and does not project to generate significant revenues if and until the U.S. Food and Drug Administration (FDA) approves its primary asset, cretostimogene. We show 9 historical shares outstanding datapoints in our CGON shares outstanding history coverage, used to compute CGON market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CGON market cap history over the course of time is important for investors interested in comparing CGON's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CGON versus a peer is one thing; comparing CGON market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CGON can fluctuate over the course of history. With this page we aim to empower investors researching CGON by allowing them to research the CGON market cap history. |
| CGON Current Stock Quote |
Quotes delayed 20 minutes  Free CGON Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CGON Share Performance |
| Market Cap Peers |
| CG Oncology (CGON) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CGTX Market Cap History CHE Market Cap History CHFS Market Cap History CHMA Market Cap History CHRS Market Cap History CI Market Cap History CINC Market Cap History CING Market Cap History CIRC Market Cap History CKPT Market Cap History More Healthcare companies » |
CGON Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
